SCHEMBL3890122

SCHEMBL3890122

CC1(c2ccccc2)CC(C(=O)O)CC(C)(c2ccccc2)N1O

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.44
KMT2A Q03164 2/20 0.41
CCR2 P41597 1/20 0.40
MAPT P10636 1/20 0.38
CYP2C19 P33261 1/20 0.38
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
HSD11B1 P28845 2/20 0.37
NOTUM Q6P988 1/20 0.37
SLC6A2 P23975 5/20 0.36
SLC6A4 P31645 4/20 0.36
SLC6A3 Q01959 3/20 0.36
CYP2D6 P10635 1/20 0.36
HTR2C P28335 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5343075 0.86 APLNR (0.44) APLNRKMT2ACCR2MAPTCYP2C19
SCHEMBL3904043 0.80 ALDH1A1 (0.36) CCR2ALDH1A1
SCHEMBL3896877 0.80 CCR2 (0.38) KMT2ACCR2MAPTHSD11B1MEN1
SCHEMBL3389800 0.75 ALDH1A1 (0.43) HSD11B1CYP2D6ALDH1A1
SCHEMBL16993536 0.72 GRIN2B (0.47) APLNRCYP2C19
SCHEMBL5466007 0.72 ALDH1A1 (0.41) HSD11B1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL17459839 0.71 CYP2C19 (0.43) APLNRKMT2ACYP2C19HSD11B1SLC6A2
SCHEMBL10550500 0.71 AKR1C1 (0.57) KMT2ACYP2C19HSD11B1MEN1ALDH1A1
SCHEMBL5342403 0.70 CCR2 (0.38) KMT2ACCR2MAPTHSD11B1MEN1
SCHEMBL416167 0.69 APLNR (0.58) APLNRKMT2AMAPTCYP2C19SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6696533-B1 MOLECULAR WEIGHT CONTROL; MONODISPERSITY BASF AKTIENGESELLSCHAFT (DE) 2004-02-24 US claimed
EP-1017728-B1 METHOD FOR PRODUCING PARTICULATE POLYMERS BY ADDITIONALLY USING A STABLE N-OXYL RADICAL BASF AG (DE) 2003-02-26 EP claimed
US-6503983-B1 Stable N-oxyl radial assisted mini emulsion polymerization BASF AKTIENGESELLSCHAFT (DE) 2003-01-07 US claimed
EP-0991672-B1 METHOD FOR AQUEOUS EMULSION POLYMERIZATION INITIATED BY FREE-RADICALS FOR PRODUCING AN AQUEOUS POLYMER DISPERSION BASF AG (DE) 2002-08-21 EP claimed
CN-107810204-B Composition for immediate termination of free radical polymerization 巴斯夫欧洲公司 2020-04-14 CN disclosed
EP-3310819-B1 COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION BASF SE (DE) 2019-06-12 EP disclosed
US-10221255-B2 Composition for the immediate stopping of a free-radical polymerization BASF SE (DE) 2019-03-05 US disclosed
US-20180171035-A1 COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION BASF SE (DE) 2018-06-21 US disclosed
EP-3310819-A1 COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION BASF SE (DE) 2018-04-25 EP disclosed
WO-2016202883-A1 COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION BASF SE (DE) 2016-12-22 WO disclosed
EP-1268561-B1 METHOD FOR PRODUCING POLYMERS BASF SE (DE) 2009-01-28 EP disclosed
US-7265166-B2 Aqueous polymer composition ROHM AND HAAS COMPANY (US) 2007-09-04 US disclosed
US-6518374-B1 Inhibitor solution, containing at least 10% phenothiazine, from 5 to 10% p-methoxyphenol and at least 50% N-methylpyrrolidone BASF AKTIENGESELLSCHAFT (DE) 2003-02-11 US disclosed
US-6518452-B1 A method of stabilizing an ester of (meth)acrylic acid against free-radical polymerization, comprising: adding to said ester of (meth)acrylic acid a polymerization inhibitor which comprises at least one nitroxyl radical and/or at least BASF AKTIENGESELLSCHAFT (DE) 2003-02-11 US disclosed
US-6503983-B1 Stable N-oxyl radial assisted mini emulsion polymerization BASF AKTIENGESELLSCHAFT (DE) 2003-01-07 US disclosed
EP-1177218-B1 METHOD OF IMMEDIATELY TERMINATING FREE-RADICAL POLYMERISATION PROCESSES BASF AG (DE) 2002-12-11 EP disclosed
EP-0991672-B1 METHOD FOR AQUEOUS EMULSION POLYMERIZATION INITIATED BY FREE-RADICALS FOR PRODUCING AN AQUEOUS POLYMER DISPERSION BASF AG (DE) 2002-08-21 EP disclosed
US-6313275-B1 FREE RADICAL CATALYSTS FOR OLEFIN (CO)POLYMERIZATION; ENDCAPPING WITH HETEROCYCLIC GROUPS; BLOCK AND GRAFT POLYMERIZATION BASF AKTIENGESELLSCHAFT (DE) 2001-11-06 US disclosed
US-H1957-H1 ADDING A PHENOTHIAZINE-CONTAINING SOLUTION WHOSE SOLVENT COMPRISES AT LEAST 50% OF ITS WEIGHT OF AN N-ALKYLPYRROLIDONE BASF AKTIENGESELLSCHAFT (DE) 2001-04-03 US disclosed
EP-1078935-A1 Pressure sensitive adhesive with improved peel strength and tack ROHM AND HAAS COMPANY (US) 2001-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10221255-B2 Composition for the immediate stopping of a free-radical polymerization FASTKD5, TYK2, FASTKD1 APLNR 3506/4885KMT2A 1484/4885CCR2 4189/4885
US-20180171035-A1 COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION FASTKD5, TYK2, FASTKD1 APLNR 3506/4885KMT2A 1484/4885CCR2 4189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.